Cargando…
Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia
Population aging has challenged the treatment of cognitive impairment or dementia. Vascular dementia is the second leading cause of dementia after Alzheimer’s disease. Cognitive consequences after ischemic brain injury have been recognized as a preferred target for therapeutic strategies, prompting...
Autores principales: | Linh, Tran Thanh Duy, Hsieh, Yi-Chen, Huang, Li-Kai, Hu, Chaur-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569827/ https://www.ncbi.nlm.nih.gov/pubmed/36232368 http://dx.doi.org/10.3390/ijms231911067 |
Ejemplares similares
-
Puerarin Alleviates Vascular Cognitive Impairment in Vascular Dementia Rats
por: Zhu, Tiantian, et al.
Publicado: (2021) -
Role of HMGB1 in an Animal Model of Vascular Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020) -
Tremor in Vascular Cognitive Impairment Raises the Possibility of Mixed Pathology With Lewy Body Disease
por: Chiu, Pai-Yi, et al.
Publicado: (2020) -
Stroke injury, cognitive impairment and vascular dementia()
por: Kalaria, Raj N., et al.
Publicado: (2016) -
Potential Therapeutics for Vascular Cognitive Impairment and Dementia
por: Sun, Miao-Kun
Publicado: (2018)